BRPI0816264A2 - composição farmacêutica que compreende a combinação de diversos agentes venotônicos e vasoprotetores para o tratamento da insuficiência venosa crônica - Google Patents

composição farmacêutica que compreende a combinação de diversos agentes venotônicos e vasoprotetores para o tratamento da insuficiência venosa crônica

Info

Publication number
BRPI0816264A2
BRPI0816264A2 BRPI0816264A BRPI0816264A BRPI0816264A2 BR PI0816264 A2 BRPI0816264 A2 BR PI0816264A2 BR PI0816264 A BRPI0816264 A BR PI0816264A BR PI0816264 A BRPI0816264 A BR PI0816264A BR PI0816264 A2 BRPI0816264 A2 BR PI0816264A2
Authority
BR
Brazil
Prior art keywords
venotonic
treatment
combination
various
pharmaceutical composition
Prior art date
Application number
BRPI0816264A
Other languages
English (en)
Inventor
Josefina Santos Murillo
Maria Elena García Armenta
Victor Guillermo Álvarez Ochoa
Original Assignee
World Trade Imp Export Wtie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by World Trade Imp Export Wtie Ag filed Critical World Trade Imp Export Wtie Ag
Publication of BRPI0816264A2 publication Critical patent/BRPI0816264A2/pt
Publication of BRPI0816264B1 publication Critical patent/BRPI0816264B1/pt
Publication of BRPI0816264B8 publication Critical patent/BRPI0816264B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0816264A 2007-09-07 2008-09-05 composição farmacêutica contendo diosmina, hesperidina e dobesilato de cálcio adequada para controle e tratamento de insuficiência venosa crônica BRPI0816264B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
MX2007011002A MX2007011002A (es) 2007-09-07 2007-09-07 Composicion farmaceutica que comprende la combinacion de diversos agentes venotonicos y vasoprotectores para el tratamiento de la insuficiencia venosa cronica.
MXMX/A/2007/011002 2007-09-07
PCT/MX2008/000119 WO2009031878A1 (es) 2007-09-07 2008-09-05 Composición farmacéutica que comprende la combinación de diversos agentes venotónicos y vasoprotectores para el tratamiento de la insuficiencia venosa crónica.

Publications (3)

Publication Number Publication Date
BRPI0816264A2 true BRPI0816264A2 (pt) 2016-01-12
BRPI0816264B1 BRPI0816264B1 (pt) 2019-05-07
BRPI0816264B8 BRPI0816264B8 (pt) 2021-05-25

Family

ID=40429084

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0816264A BRPI0816264B8 (pt) 2007-09-07 2008-09-05 composição farmacêutica contendo diosmina, hesperidina e dobesilato de cálcio adequada para controle e tratamento de insuficiência venosa crônica

Country Status (12)

Country Link
EP (1) EP2208498B8 (pt)
AR (1) AR068820A1 (pt)
BR (1) BRPI0816264B8 (pt)
CL (1) CL2008002665A1 (pt)
CO (1) CO6260085A2 (pt)
CY (1) CY1115245T1 (pt)
EC (1) ECSP10010011A (pt)
ES (1) ES2466318T3 (pt)
GT (1) GT201000053A (pt)
MX (1) MX2007011002A (pt)
PL (1) PL2208498T3 (pt)
WO (1) WO2009031878A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3987C2 (ro) * 2009-09-03 2010-07-31 Георге АНГЕЛИЧ Utilizare a Diosminei pentru tratamentul cirozei hepatice avansate asociate cu insuficienţă cardiacă
MD3986C2 (ro) * 2009-09-23 2010-07-31 Георге АНГЕЛИЧ Utilizare a Diosminei pentru tratamentul gastropatiilor portale în ciroza hepatică
EP2353596A1 (en) * 2010-02-02 2011-08-10 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency
JP5923044B2 (ja) * 2010-04-09 2016-05-24 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニＳｉｇｍａ−Ｔａｕ Ｉｎｄｕｓｔｒｉｅ Ｆａｒｍａｃｅｕｔｉｃｈｅ Ｒｉｕｎｉｔｅ Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ 活性成分としてｌ−カルニチンまたはプロピオニルｌ−カルニチンを含む慢性静脈不全の予防または治療のための併用組成物
MD4231C1 (ro) * 2012-11-08 2014-01-31 Георге АНГЕЛИЧ Remediu medicamentos pe bază de troxerutin şi carbazocrom pentru tratamentul gastropatiilor portale în ciroza hepatică
MD4232C1 (ro) * 2012-11-08 2014-01-31 Георге АНГЕЛИЧ Remediu medicamentos pe bază de troxerutin şi carbazocrom pentru tratamentul cirozei hepatice avansate asociate cu insuficienţă cardiacă
WO2014184398A1 (es) * 2013-05-14 2014-11-20 Figueiredo Rodriguez Graciela Formula farmacéutica para el tratamiento de afecciones que involucran al sistema venoso y linfático, al sobrepeso y la obesidad
FR3019820B1 (fr) * 2014-04-15 2017-07-21 Peter Weyts Composes de type flavonoides pour leur utilisation dans le traitement d'une pathologie du pied d'un mammifere ongule-composition pharmaceutique associee
RU2570544C1 (ru) * 2014-08-12 2015-12-10 Закрытое акционерное общество "Санаторий "Предгорье Кавказа" Способ комплексного лечения хронической венозной недостаточности при варикозной болезни нижних конечностей в санаторно-курортных условиях
AU2016217912A1 (en) * 2015-02-11 2017-09-28 Bioactor Bv Compounds and compositions for improving power output and oxygen efficiency
CN114712324B (zh) * 2022-05-06 2024-04-16 海南林恒制药股份有限公司 一种羟苯磺酸钙胶囊及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726469B1 (fr) * 1994-11-08 1996-12-13 Adir Composition pharmaceutique pour l'administration orale de flavonoides

Also Published As

Publication number Publication date
CL2008002665A1 (es) 2009-03-20
CY1115245T1 (el) 2017-01-04
ES2466318T3 (es) 2014-06-10
WO2009031878A1 (es) 2009-03-12
PL2208498T3 (pl) 2014-09-30
EP2208498A1 (en) 2010-07-21
GT201000053A (es) 2016-01-21
MX2007011002A (es) 2009-03-09
BRPI0816264B1 (pt) 2019-05-07
CO6260085A2 (es) 2011-03-22
EP2208498B1 (en) 2014-02-26
EP2208498B8 (en) 2014-06-11
AR068820A1 (es) 2009-12-09
EP2208498A4 (en) 2010-11-17
ECSP10010011A (es) 2010-04-30
BRPI0816264B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
BRPI0816264A2 (pt) composição farmacêutica que compreende a combinação de diversos agentes venotônicos e vasoprotetores para o tratamento da insuficiência venosa crônica
BRPI0915341A2 (pt) artigo absorvente que compreende uma região ativada
DK2154971T3 (da) Synergistisk farmaceutisk kombination til behandling af cancer
CL2008000754A1 (es) Compuesto derivado de heterociclos de nitrogeno; composicion farmaceutica que comprende a dicho compuesto; y uso para tratar cancer y trastornos hiperproliferativos.
BRPI0911669A8 (pt) sistemas e métodos para o aperfeiçoamento da eficiência da disposição de orifício de catéter
BRPI0818625A2 (pt) Composições de cuidados pessoais que compreendem sulfatos de undecila
BRPI0815760A2 (pt) Composição dermatológica injetável para o tratamento de rugas
BRPI0815170A2 (pt) Composição farmacêutica que compreende um inibidor de sglt 2
BRPI0715712A2 (pt) Composição farmacêutica
BRPI1013642A2 (pt) derivado de triazina e composição farmacêutica compreendendo o mesmo
BRPI0719393A2 (pt) Composição farmacêutica
BRPI0716445A2 (pt) composiÇço farmacÊutica
BRPI0718428A2 (pt) Composição de ibuprofeno
BRPI0819105A2 (pt) composição para o tratamento e prevenção de edema de pálpebra
BRPI0720234A2 (pt) Composição farmacêutica
BR112013014189A2 (pt) composição farmacêutica que compreende transcinamaldeíco e o uso da mesma no tratamento de infecções
BRPI0810091A2 (pt) Agentes fugicidas tópicos para tratar distúrbios ungueais
BRPI0912890A2 (pt) composição farmacêutica para o tratamento de ejaculação precoce
BRPI0822782A2 (pt) composição farmacêutica que compreende rosuvastatina
BRPI0810762A2 (pt) Composição para tratamento da água
BRPI0812988A2 (pt) Composição farmacêutica que compreende a combinação de uma triazolobenzodiazepina e um agente inibidor seletivo da recaptura da serotonina
BRPI0811629A2 (pt) Composição farmacêutica que compreende a combinação de um agente anti-inflamatório e um agente anticonvulsivo
CL2008000093A1 (es) Compuestos derivados de piridina, inhibidores de p2y12; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de un desorden de agregacion plaquetaria.
DK2046323T3 (da) Sammensætninger som bidrager til behandling af cancer
BRPI0912679A2 (pt) composição farmacêutica para o tratamento de fibromialgia

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: PPTM INTERNATIONAL, S.A.R.L. (LU)

B25A Requested transfer of rights approved

Owner name: TEVA PHARMACEUTICALS HOLDINGS MEXICO S.A. DE C.V.

B25A Requested transfer of rights approved

Owner name: REPRESENTACIONES E INVESTIGACIONES MEDICAS S.A. DE

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 07/05/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 07/05/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/09/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF